Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial

Journal:

The Lancet

Published:

2025-10-20

DOI:

10.1016/s0140-6736(25)01848-3

Affiliations:

51

Authors:

57

Go to article

Institutions	Authors	Share
Akeso, Inc, China	5.000000	0.09
Hunan Cancer Hospital, China	3.000000	0.05
Shanghai Chest Hospital, SJTU, China	2.000000	0.04
First Affiliated Hospital, AHMU, China	2.000000	0.04
Fourth Hospital of Hebei Medical University, China	2.000000	0.04
The Third Xiangya Hospital, CSU, China	1.000000	0.02
Henan Cancer Hospital, ZZU, China	1.000000	0.02
SUMC Affiliated Cancer Hospital, China	1.000000	0.02
Daping Hospital, Army Medical University, China	1.000000	0.02
Anhui Provincial Cancer Hospital, China	1.000000	0.02
Jiangxi Provincial Cancer Hospital, China	1.000000	0.02
Gansu Wuwei Tumor Hospital, China	1.000000	0.02
Fujian Cancer Hospital, China	1.000000	0.02
First Affiliated Hospital, ZZU, China	1.000000	0.02
Zhejiang Cancer Hospital (ZJCH), China	1.000000	0.02
The First Affiliated Hospital of Henan University of Science and Technology, China	1.000000	0.02
Qingdao Central Hospital, China	1.000000	0.02
Ningbo Medical Center Li Huili Hospital, China	1.000000	0.02
First Affiliated Hospital, USC, China	1.000000	0.02
The First Affiliated Hospital, SYSU, China	1.000000	0.02
Xiangya Hospital, CSU, China	1.000000	0.02
The Second Affiliated Hospital, Zhejiang University School of Medicine, China	1.000000	0.02
Tangshan People Hospital, China	1.000000	0.02
Tongji Hospital (TJH), HUST, China	1.000000	0.02
The First Affiliated Hospital, Zhejiang University School of Medicine, China	1.000000	0.02
The Second Affiliated Hospital of Xiamen Medical College, China	1.000000	0.02
The First Affiliated Hospital of Xinxiang Medical University, China	1.000000	0.02
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China	1.000000	0.02
Sichuan Cancer Hospital, China	1.000000	0.02
Harbin Medical University Cancer Hospital, China	1.000000	0.02
Affiliated Hospital of Guangdong Medical University, GDMU, China	1.000000	0.02
Affiliated Hospital, XZMC, China	1.000000	0.02
The First Affiliated Hospital, USTC, China	1.000000	0.02
The First Affiliated Hospital of Chongqing Medical University, China	1.000000	0.02
Affiliated Cancer Hospital of Guangzhou Medical University, China	1.000000	0.02
Jilin Province Cancer Hospital, China	1.000000	0.02
The First Affiliated Hospital of Nanchang University, China	1.000000	0.02
Jiamusi Tumor Hospital, China	1.000000	0.02
Beijing Cancer Hospital / School of Oncology, PKUHSC, China	1.000000	0.02
Hospital and Cancer Center, CQU, China	1.000000	0.02
Linyi People's Hospital, China	1.000000	0.02
Cancer Hospital of Yunnan Province, China	1.000000	0.02
Taizhou Central Hospital, China	1.000000	0.02
First Affiliated Hospital of Ningbo University, China	1.000000	0.02
Shandong Cancer Hospital, China	1.000000	0.02
Changsha Central Hospital, China	1.000000	0.02
Fuzhou Pulmonary Hospital of Fujian, China	1.000000	0.02
The First Affiliated Hospital of Gannan Medical University, China	0.500000	0.01
Jining First People's Hospital, China	0.500000	0.01

Interested in Oncology and Carcinogenesis?